Employers Wary Of Disease Management; Pfizer Takes Model To Employees
Executive Summary
Insurers appear to be steering employers away from pharmaceutical industry disease management programs with the message that they are not cost effective
You may also be interested in...
Pfizer Ready For Medicare Formularies, CEO Says; Humana JV Begins
Pfizer does not expect implementation of Medicare Rx formularies to have a significant impact on access to its products, CEO Hank McKinnell said during the company's Jan. 19 sales and earnings call
Pfizer Florida Medicaid Program Yields Savings Of $42 Mil. After Two Years
Pfizer is in discussions with Florida's Agency for Health Care Administration about a potential expansion of the company's Medicaid disease management program
Disease Management Program Cost Savings Not Yet Demonstrated – CBO
There is "insufficient evidence" to find that disease management programs help lower overall health care spending, the Congressional Budget Office says